Circulating tumor cells PD‐L1 expression detection and correlation of therapeutic efficacy of immune checkpoint inhibition in advanced non‐small‐cell lung cancer

Circulating tumor cells PD‐L1 expression detection and correlation of therapeutic efficacy of immune checkpoint inhibition in advanced non‐small‐cell lung cancer

Abstract Introduction This study investigated whether programmed death‐ligand 1 (PD‐L1) expression of circulating tumor cells (CTCs) in peripheral blood can serve as a predictive biomarker for immunotherapy efficacy in patients with advanced non‐small‐cell lung cancer (NSCLC). Methods We employed a...

Full description

Bibliographic Details
Main Authors: Qing Zhou, Xiangning Liu, Ji Li, Bing Tong, Yan Xu, Minjiang Chen, Xiaoyan Liu, Xiaoxing Gao, Yuequan Shi, Jing Zhao, Wei Zhong, Mengzhao Wang
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Thoracic Cancer
Subjects:
circulating tumor cells
immunotherapy
non‐small‐cell lung cancer
programmed death‐ligand 1
Online Access:https://doi.org/10.1111/1759-7714.14767

Internet

https://doi.org/10.1111/1759-7714.14767

Similar Items